All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, Ángela Gil‐Martin et al.|Hepatology|2018Cited by 79
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemiaCristina Rueda, Rafael Zaragoza, Carlos García-Cerrada et al.|Clinical Microbiology and Infection|2016Cited by 57
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohortLuis Eduardo López-Cortés, David Navarro, Benito Almirante et al.|Clinical Microbiology and Infection|2016Cited by 39
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1Juan Berenguer, Juan González‐García, José Luís Calleja et al.|Open Forum Infectious Diseases|2019Cited by 4
WED-005 Current hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus across EuropeAnders Boyd, Pablo Ryan, Lutz Thomas et al.|Journal of Hepatology|2025Cited by 1